Maruyama M, Kudo T, Kuwabara H, Yoshida T, Sugano N, Ebuchi M
Dept. of Surgery, Tokyo Metropolitan Ohkubo Hospital.
Gan To Kagaku Ryoho. 1998 Apr;25(5):691-6.
The authors analyzed the histological effect of preoperative chemotherapy for 41 colorectal advanced cancer patients using resected specimens. Twenty patients in the UFT + LV group received 400 mg/day of UFT and 30 mg/day of leucovorin for 10-14 days just before the operations. Twenty-one patients with UFT alone received UFT 400 mg/day during the same period. Only one patient in the UFT + LV group developed the side effect of mild leukocytopenia. The histological effect of the UFT + LV group was superior to that of the UFT alone group (p = 0.03). The number of Grade 1a and 1b in the UFT + LV group was 14 (60.9%) and 7 (30.4%), while in the UFT group 16 (66.7%) and 2 (8.3%). Histological examination revealed no lesions which showed Grade 2 and 3 in both groups. There was the tendency for the histological effect in moderately differentiated adenocarcinomas to be superior to that in well-differentiated adenocarcinomas in both group. The histological effect in metastatic lymph nodes was superior to that in the original colorectal lesions in both groups. This suggests preoperative chemotherapy with UFT + LV and UFT could achieve the clinical down-staging of advanced colorectal cancer.
作者使用切除标本分析了术前化疗对41例结直肠癌晚期患者的组织学效果。UFT+LV组的20例患者在手术前10 - 14天接受每天400毫克的UFT和每天30毫克的亚叶酸。21例单纯使用UFT的患者在同一时期接受每天400毫克的UFT。UFT+LV组只有1例患者出现轻度白细胞减少的副作用。UFT+LV组的组织学效果优于单纯UFT组(p = 0.03)。UFT+LV组1a级和1b级的数量分别为14例(60.9%)和7例(30.4%),而UFT组为16例(66.7%)和2例(8.3%)。组织学检查显示两组均无2级和3级病变。两组中,中分化腺癌的组织学效果均有优于高分化腺癌的趋势。两组中转移淋巴结的组织学效果均优于原发结直肠病变。这表明UFT+LV和UFT术前化疗可实现晚期结直肠癌的临床降期。